Ziccum AB has signed an Evaluation agreement with a Biopharmaceutical Corporation focused on mRNA technologies to commence a Feasibility study regarding LaminarPace for ambient drying of mRNA/LNP. | May 9, 2023
Read more about Covaxin capacity scaled up to 500 million doses a year: Bharat Biotech on Business Standard. Vaccine effective against all emerging coronavirus variants, says study
Augmenting #COVID19Vaccine supplies on war footing!
Production of #Covaxin to be increased from 1 cr doses/month currently to 10 cr by Sep 2021 by enhancing capacity & adding more manufacturers
Grants for same are being provided by @DBTIndia under its mission COVID suraksha. pic.twitter.com/XrHiFMQsiA
“Production of Covaxin to be increased from 1 cr doses per month to 10 cr by Sep 2021 by enhancing capacity and adding more manufacturers. Grants for the same are being provided by DBTIndia under its